Search Results - "Avezum, Á"

Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries by Yusuf, Salim, Rangarajan, Sumathy, Teo, Koon, Islam, Shofiqul, Li, Wei, Liu, Lisheng, Bo, Jian, Lou, Qinglin, Lu, Fanghong, Liu, Tianlu, Yu, Liu, Zhang, Shiying, Mony, Prem, Swaminathan, Sumathi, Mohan, Viswanathan, Gupta, Rajeev, Kumar, Rajesh, Vijayakumar, Krishnapillai, Lear, Scott, Anand, Sonia, Wielgosz, Andreas, Diaz, Rafael, Avezum, Alvaro, Lopez-Jaramillo, Patricio, Lanas, Fernando, Yusoff, Khalid, Ismail, Noorhassim, Iqbal, Romaina, Rahman, Omar, Rosengren, Annika, Yusufali, Afzalhussein, Kelishadi, Roya, Kruger, Annamarie, Puoane, Thandi, Szuba, Andrzej, Chifamba, Jephat, Oguz, Aytekin, McQueen, Matthew, McKee, Martin, Dagenais, Gilles

“…In a large study, cardiac risk-factor burden was correlated with cardiovascular disease and mortality. High-income countries had a high risk burden but low…”
Get full text

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data by Khatib, Rasha, PhD, McKee, Martin, Prof, Shannon, Harry, Prof, Chow, Clara, PhD, Rangarajan, Sumathy, MSc, Teo, Koon, Prof, Wei, Li, Prof, Mony, Prem, MD, Mohan, Viswanathan, MD, Gupta, Rajeev, PhD, Kumar, Rajesh, MD, Vijayakumar, Krishnapillai, Prof, Lear, Scott A, Prof, Diaz, Rafael, MD, Avezum, Alvaro, PhD, Lopez-Jaramillo, Patricio, Prof, Lanas, Fernando, MD, Yusoff, Khalid, Prof, Ismail, Noorhassim, MD, Kazmi, Khawar, MBBS, Rahman, Omar, Prof, Rosengren, Annika, Prof, Monsef, Nahed, MD, Kelishadi, Roya, Prof, Kruger, Annamarie, Prof, Puoane, Thandi, Prof, Szuba, Andrzej, Prof, Chifamba, Jephat, PhD, Temizhan, Ahmet, MD, Dagenais, Gilles, Prof, Gafni, Amiram, Prof, Yusuf, Salim, Prof

“…Summary Background WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible…”
Get full text

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES by Vanassche, Thomas, Lauw, Mandy N, Eikelboom, John W, Healey, Jeff S, Hart, Robert G, Alings, Marco, Avezum, Alvaro, Díaz, Rafael, Hohnloser, Stefan H, Lewis, Basil S, Shestakovska, Olga, Wang, Jia, Connolly, Stuart J

“…The pattern of atrial fibrillation (AF) occurrence-paroxysmal, persistent, or permanent-is associated with progressive stages of atrial dysfunction and…”
Get full text

Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry by Devlin, G, Anderson, F A, Heald, S, López-Sendón, J, Avezum, Á, Elliott, J, Dabbous, O H, Brieger, D

“…Objective: To document patterns of risk stratification, management practices, and outcomes among patients with acute coronary syndromes (ACS) presenting…”
Get full text

Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score by MCGORRIAN, Catherine, YUSUF, Salim, DANS, Antonio L, GERSTEIN, Hertzel C, TEO, Koon, ANAND, Sonia S, ISLAM, Shofiqul, JUNG, Hyejung, RANGARAJAN, Sumathy, AVEZUM, Alvaro, PRABHAKARAN, Dorairaj, ALMAHMEED, Wael, RUMBOLDT, Zvonko, BUDAJ, Andrzej

“…Summating risk factor burden is a useful approach in the assessment of cardiovascular risk among apparently healthy individuals. We aimed to derive and…”
Get full text

Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE) by Fox, K. A. A., Goodman, S. G., Klein, W., Brieger, D., Steg, P. G., Dabbous, O., Avezum, Á.

“…Aims Despite advances in the treatment of acute coronary syndromes based on randomized trial data and published guidelines, the extent to which such treatments…”
Get full text

Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events by Brieger, D, Fox, K A A, Fitzgerald, G, Eagle, K A, Budaj, A, Avezum, A, Granger, C B, Costa, B, Anderson, Jr, F A, Steg, Ph G

“…To identify patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) with a low likelihood of any adverse in-hospital event. Data were analysed from…”
Get more information

Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study by Rosengren, A, Subramanian, S V, Islam, S, Chow, C K, Avezum, A, Kazmi, K, Sliwa, K, Zubaid, M, Rangarajan, S, Yusuf, S

“…To determine the effect of education and other measures of socioeconomic status (SES) on risk of acute myocardial infarction (AMI) in patients and controls…”
Get more information

Comparison of candesartan, enalapril, and their combination in congestive Heart failure : Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study the resolvd pilot study investigators by MCKELVIE, R. S, YUSUF, S, MAGGIONI, A, YOUNG, J, POGUE, J, PERICAK, D, AVEZUM, A, BURNS, R. J, PROBSTFIELD, J, TSUYUKI, R. T, WHITE, M, ROULEAU, J, LATINI, R

“…We investigated the effects of candesartan (an angiotensin II antagonist) alone, enalapril alone, and their combination on exercise tolerance, ventricular…”
Get full text

Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study by Anand, SS, Dagenais, GR, Mohan, V, Diaz, R, Probstfield, J, Freeman, R, Shaw, J, Lanas, F, Avezum, A, Budaj, A, Jung, H, Desai, D, Bosch, J, Yusuf, S, Gerstein, HC

“…Aims: In an international prospective cohort study we assessed the relationship between glucose levels and incident cardiovascular events and death. Methods…”
Get full text

Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events by Steg, Ph. Gabriel, Fox, Keith A.A., Eagle, Kim A., Furman, Mark, Van de Werf, Frans, Montalescot, Gilles, Goodman, Shaun G., Avezum, Álvaro, Huang, Wei, Gore, Joel M.

“…Aims To assess mortality after drug-eluting stent (DES) or bare-metal stent (BMS) for ST-segment elevation myocardial infarction (STEMI). Methods and results…”
Get full text

Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes by Chew, D P, Anderson, F A, Avezum, A, Eagle, K A, FitzGerald, G, Gore, J M, Dedrick, R, Brieger, D

“…The authors sought to define which guideline-advocated therapies are associated with the greatest benefit with respect to 6-month survival in patients…”
Get more information

Psychosocial factors and obesity in 17 high-, middle- and low-income countries: the Prospective Urban Rural Epidemiologic study by Rosengren, A, Teo, K, Rangarajan, S, Kabali, C, Khumalo, I, Kutty, V R, Gupta, R, Yusuf, R, Iqbal, R, Ismail, N, Altuntas, Y, Kelishadi, R, Diaz, R, Avezum, A, Chifamba, J, Zatonska, K, Wei, L, Liao, X, Lopez-Jaramillo, P, Yusufali, A, Seron, P, Lear, S A, Yusuf, S

“…Background/Objectives: Psychosocial stress has been proposed to contribute to obesity, particularly abdominal, or central obesity, through chronic activation…”
Get full text

Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes by Gerstein, H C, Mohan, V, Avezum, A, Bergenstal, R M, Chiasson, J-L, Garrido, M, MacKinnon, I, Rao, P V, Zinman, B, Jung, H, Joldersma, L, Bosch, J, Yusuf, S

“…Aims/hypothesis The Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication (DREAM) trial reported that 3 years of therapy with rosiglitazone…”
Get full text

Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE) by Santopinto, J J, Fox, K A A, Goldberg, R J, Budaj, A, Piñero, G, Avezum, A, Gulba, D, Esteban, J, Gore, J M, Johnson, J, Gurfinkel, E P

“…Objective: To determine whether creatinine clearance at the time of hospital admission is an independent predictor of hospital mortality and adverse outcomes…”
Get full text

Rationale and design of INTERSTROKE: a global case-control study of risk factors for stroke by O'Donnell, M, Xavier, D, Diener, C, Sacco, R, Lisheng, L, Zhang, H, Pias, P, Truelsen, T, Chin, S L, Rangarajan, S, Devilliers, L, Damasceno, A, Mondo, C, Lanas, F, Avezum, A, Diaz, R, Varigos, J, Hankey, G, Teal, P, Kapral, M, Ryglewicz, D, Czlonkowska, A, Skowronska, M, Lopez-Jaramillo, P, Dans, T, Langhorne, P, Yusuf, S

“…Stroke is a major global health problem. It is the third leading cause of death and the leading cause of adult disability. INTERHEART, a global case-control…”
Get more information

Assessing global risk factors for non-fatal injuries from road traffic accidents and falls in adults aged 35-70 years in 17 countries: a cross-sectional analysis of the Prospective Urban Rural Epidemiological (PURE) study by Raina, Parminder, Sohel, Nazmul, Oremus, Mark, Shannon, Harry, Mony, Prem, Kumar, Rajesh, Li, Wei, Wang, Yang, Wang, Xingyu, Yusoff, Khalid, Yusuf, Rita, Iqbal, Romaina, Szuba, Andrzej, Oguz, Aytekin, Rosengren, Annika, Kruger, Annamarie, Chifamba, Jephat, Mohammadifard, Noushin, Darwish, Ebtihal Ahmad, Dagenais, Gilles, Diaz, Rafael, Avezum, Alvaro, Lopez-Jaramillo, Patricio, Seron, Pamela, Rangarajan, Sumathy, Teo, Koon, Yusuf, Salim

“…To assess risk factors associated with non-fatal injuries (NFIs) from road traffic accidents (RTAs) or falls. Our study included 151 609 participants from the…”
Get more information

Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes

“…Background Acute coronary syndromes (ACS), including the spectrum of conditions from unstable angina to ST segment elevation myocardial infarction, represent a…”
Get full text

Cardiovascular disease in South America: current status and opportunities for prevention by Avezum, A, Braga, J, Santos, I, Guimarães, H P, Marin-Neto, J A, Piegas, L S

“…South America comprises widely different environments consisting of many complex and heterogeneous ethnicities, societies and cultures. During recent decades…”
Get more information

Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial by Anand, Sonia S., Eikelboom, John W., Dyal, Leanne, Bosch, Jackie, Neumann, Christoph, Widimsky, Petr, Avezum, Alvaro A., Probstfield, Jeffrey, Cook Bruns, Nancy, Fox, Keith A.A., Bhatt, Deepak L., Connolly, Stuart J., Yusuf, Salim

“…The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) trial showed that the combination of low-dose rivaroxaban and aspirin reduced…”
Get full text